v3.26.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Ordinary Shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive income/(loss)
Non- controlling interest
Total
Balance at Mar. 31, 2023 $ 1,185 [1] $ 84,241,600 $ 1,309,109 $ (69,273,018) $ 1,735,135 $ (1,346,859) $ 16,667,152
Balance (in Shares) at Mar. 31, 2023 [1] 7,900            
Fractional shares issued for reverse stock split $ 60 [1] (60)
Fractional shares issued for reverse stock split (in Shares) [1] 403            
Issuance of shares and warrants in private placements $ 498 [1] 2,589,102         2,589,600
Issuance of shares and warrants in private placements (in Shares) [1] 3,320            
Net (loss) income [1] (4,234,228) (14) (4,234,242)
Foreign currency translation difference [1] (729,373) (729,373)
Balance at Mar. 31, 2024 $ 1,743 [1] 86,830,642 1,309,109 (73,507,246) 1,005,762 (1,346,873) 14,293,137
Balance (in Shares) at Mar. 31, 2024 [1] 11,623            
Cancellation of shares $ (55) [1] 55
Cancellation of shares (in Shares) [1] (367)            
Divestiture of Jiuxin Investment $ (2,548) [1] (4,896,722) (1,309,109) (2,440,344) 1,341,489 (7,307,234)
Divestiture of Jiuxin Investment (in Shares) [1] (16,989)            
Acquisition of Ridgeline $ 2,225 [1] 3,580,025 3,582,250
Acquisition of Ridgeline (in Shares) [1] 14,833            
Sale of shares and in a private placement, net $ 4,490 [1] 7,628,510 7,633,000
Sale of shares and in a private placement, net (in Shares) [1] 29,933            
Net (loss) income [1] 10,194,467 5,384 10,199,851
Foreign currency translation difference [1] 1,235,378 1,235,378
Balance at Mar. 31, 2025 $ 5,855 [1] 93,142,510 (63,312,779) (199,204)   29,636,382
Balance (in Shares) at Mar. 31, 2025 [1] 39,033            
Sale of shares and in a private placement, net $ 119,485 [1] 10,763,772 10,883,257
Sale of shares and in a private placement, net (in Shares) [1] 796,567            
Cashless exercise of stock warrants $ 7,751 [1] (7,751)
Cashless exercise of stock warrants (in Shares) [1] 51,671            
Net (loss) income [1] (1,250,422) (1,250,422)
Foreign currency translation difference [1] 1,507,421 1,507,421
Balance at Mar. 31, 2026 $ 133,091 [1] $ 103,898,531 $ (64,563,201) $ 1,308,217 $ 40,776,638
Balance (in Shares) at Mar. 31, 2026 [1] 887,271            
[1] All share numbers and share amounts presented have been retroactively adjusted to reflect the 1-for-150 reverse share split effective April 7, 2026.